Leon ZachariasChristian AbegglenChristopher Pawlak2024-07-042024-07-042024-07-01https://www.alexandria.unisg.ch/handle/20.500.14171/120460This report, authored by Christian Abegglen, Christopher Pawlak, and Leon Zacharias, investigates the balance between agility and resilience in pharmaceutical supply chains amidst these changes. The study focuses on how pharmaceutical companies can adapt their operational capabilities to remain competitive in a volatile environment. Utilizing a mixed-method survey conducted during the Pharmap 2024 conference in Amsterdam, the research captures insights from industry experts. Findings indicate that a combination of agility and resilience is crucial for navigating disruptions. Agility enables rapid adaptation to market changes, while resilience ensures long-term sustainability by withstanding and recovering from significant disruptions. The report embeds these findings into the St. Gallen Management Concept, offering a holistic approach to align strategies with operational capabilities and cultural readiness. The implications suggest that pharmaceutical companies should foster a culture of continuous learning and innovation, integrate advanced technologies, and enhance strategic initiatives to maintain stability and competitiveness.en-USPharmaceutical industrySupply chain managementAgilityResilienceDisruptive innovationsOperational capabilitiesTechnological advancementsStrategic initiativesContinuous learningSt. Gallen Management ConceptMarket adaptationLong-term sustainabilityCompetitive advantageRisk managementDigital transformationjournal article